Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

C Sixty Inc.

This article was originally published in Start Up

Executive Summary

C Sixty Inc. aims to find commercial applications for Buckminsterfullerene, a sixty-carbon atom (C60) molecule and only the third form of elemental carbon found in nature, at the intersection of nano- and biotechnologies. According to the company's CEO, Uri Sagman, these soccer ball-shaped and nanometer-sized Buckyballs have potential futures as therapeutics, drug delivery scaffolds, and components of medical devices and diagnostics. Furthest along in the C Sixty pipeline are an anti-HIV protease compound and a compound designed to treat neurodegenerative disorders.
Advertisement

Related Content

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC090538

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel